Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety of SPD417 Combined With Other Psychotropic Medications in the Treatment of Bipolar I Disorder
This study has been completed.
Study NCT00150605   Information provided by Validus Pharmaceuticals

First Received on September 6, 2005.   Last Updated on November 1, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Bipolar Disorder
More general conditions related to this trial
Affective Disorders, Psychotic
Mental Disorders
Mood Disorders
Interventions listed in this trial
Extended-release carbamazepine
Additional drug interventions recognized in this trial
Carbamazepine
Psychotropic Drugs
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anticonvulsants
Antimanic Agents
Central Nervous System Agents
Central Nervous System Depressants
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
Validus Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services